Molecular Research in Vaccinology and Vaccine Development
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 3930
Special Issue Editor
Special Issue Information
Dear Colleagues,
Vaccines play an utmost role in both human and veterinary medicine. The roots of vaccinology and immunprophylaxis is dating back to 19. century, the work of Louis Pasteur (1822–1895) and Robert Koch (1843–1910). The idea of vaccines emerged realising we could be able to “teach” immune system to the fight against specific pathogens providing attenuated agents which do not trigger clinical symptoms and generates onset of immunity. Applying this approach our vaccines as specific products with biological profile must be compliant to the following criteria: (i.) safety; (ii.) efficacy; (iii.) potency and (iv.) purity. Both the industrial production and authority control serve the completion of these four criteria. Nowadays many particular types of vaccines are at our disposal from the so-called inactivated vaccines to the RNA-based ones. In this special issue, discussions about the example veterinary and human virus the evolution and specific types of vaccines are all welcomed.
Dr. Attila Farsang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- vaccinology
- immunology mechanisms
- vaccine vectors
- gene vaccines
- infection
- host–pathogen interactions and responses
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
